AREN Q1 2026 Earnings EPS Misses Expectations by Wide Margin Stock Climbs Despite Loss BioVie Inc Q1 2026 Earnings EPS Beat Amid Ongoing Clinical Development PAM Q1 2026 Earnings Staggering EPS Beat as Operating Performance Surges PRLD Q1 2026 Earnings NarrowerThanExpected Loss as Clinical Pipeline Advances TUYA Q1 2026 Earnings Narrow EPS Miss Leaves Stock Flat Amid Steady Operations IMCR Q1 2026 Earnings Surprise Profitability Defies Expectations with No Reported Revenue